MedTrace Logo

Culture of Circulating Tumor Cells Isolated From Cancer Patients With Metastatic Disease

NCT02781025 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 42

Last updated 2021-12-22

No results posted yet for this study

Summary

The purpose of this study is to investigate the feasibility of using novel decellularized tissue matrices to isolate and culture circulating tumor cells (CTCs) collected from patients with metastatic solid tumor malignancies.

Conditions

  • Circulating Tumor Cells

Interventions

OTHER

Blood draw

A blood sample of 10mL- 25mL will be collected before the start of radiation treatment.

Sponsors & Collaborators

  • UNC Lineberger Comprehensive Cancer Center

    lead OTHER

Principal Investigators

  • Andrew Wang, MD · University of North Carolina, Chapel Hill

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-30
Primary Completion
2020-12-30
Completion
2020-12-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02781025 on ClinicalTrials.gov